# Nerbio iTOF

> Remote monitoring software

Canonical page: [https://chrome-stats.com/d/id1525979662](https://chrome-stats.com/d/id1525979662)

## Overview

- **ID:** `id1525979662`
- **Platform:** Apple
- **Type:** Apple app
- **Status:** Available
- **Publisher:** Nerbio Medical Software Platform Inc
- **Category:** Medical
- **Rating:** 5.00 / 5 (3 ratings)
- **Version:** 2.0.3
- **Last updated:** 2026-02-03
- **First published:** 2023-03-21
- **Size:** 87 MB
- **Data as of:** 2026-09-04
- **Store listing:** [Apple App Store](https://apps.apple.com/us/app/nerbio-itof/id1525979662)
- **Website:** [https://nerbio.com/](https://nerbio.com/)
- **Privacy policy:** [https://nerbio.com/privacy](https://nerbio.com/privacy)

## Description

Nerbio’s iTOF® app works with the iTOF device; an FDA cleared, quantitative neuromuscular transmission (NMT) monitor for remote monitoring of neuromuscular blocking agents (NMBAs).

The iTOF app is designed to make patient monitoring safer, easier to use, and more accurate than ever. The iTOF is the first mobile device-managed, quantitative monitor of NMBAs. The combination of the app and Bluetooth-connected stimulator device allows precise, automated quantitative monitoring of the level of neuromuscular block. Wireless control also improves caregiver safety while maintaining a high-level of patient care. The iTOF system is recommended by leading anesthesiologists and used around the world for accurate NMBA monitoring.
-------------------------------
NOTE: This app requires the iTOF device hardware to perform monitoring. Contact nerbio.com for information. iTOF is a registered trademark of Nerbio Medical Software Platforms, Inc. San Jose, California USA.
-------------------------------
NOTE: Nerbio’s iTOF is authorized for use in the following countries:
USA
CHILE
COLOMBIA
INDIA
-------------------------------

## Rankings

- #554,219 — Overall

## Similar extensions and apps

- [Noraxon Biofeedback](https://chrome-stats.com/d/id6744024468)
- [NEURO TOUCH](https://chrome-stats.com/d/id1660782305)
- [Nivolis-Meto](https://chrome-stats.com/d/id6753065804)
- [Patient Controller NR - US](https://chrome-stats.com/d/id1059237634) — 2.40 / 5
- [NiNA](https://chrome-stats.com/d/id1581855123) — 5.00 / 5
- [Patient Controller NR - EMEA2](https://chrome-stats.com/d/id1127457714)
- [BTM Assist](https://chrome-stats.com/d/id1449693253) — 5.00 / 5
- [Patient Controller NR – EU](https://chrome-stats.com/d/id973338477)
- [Patient Controller NR - LATAM](https://chrome-stats.com/d/id1177791721) — 4.00 / 5
- [Patient Controller NR - CAN](https://chrome-stats.com/d/id1114594277)
- [Patient Controller NR - CHN](https://chrome-stats.com/d/id1669817303)
- [NarigMed](https://chrome-stats.com/d/id1537792284)

---

Source: [Chrome-Stats](https://chrome-stats.com/d/id1525979662)